Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inotiv, Inc. Director's Dealing 2019

Mar 1, 2019

34595_dirs_2019-03-01_54b9da3d-6364-484d-8684-708beb156488.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2019-02-19

Reporting Person: Sagartz John E (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-02-19 Common Shares L 2500 $1.43 Acquired 2500 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Shares 617625 Indirect

Footnotes

F1: The Reporting Person owns 41.175% of the outstanding equity interests of SW Chrysalis, LLC, a Delaware limited liability company, which owns 1,500,000 common shares of the Issuer. The Reporting Person is Co-President and Chief Strategy Officer of SW Chrysalis, LLC.